The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Apr. 17, 2014
Applicant:

University of Saskatchewan, Saskatoon, CA;

Inventors:

Gregg Patrick Adams, Saskatoon, CA;

Maria Jimena Yapura, Palmerston North, NZ;

Roger A. Pierson, Saskatoon, CA;

Ildiko Badea, Saskatoon, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4196 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 47/44 (2017.01); A61K 31/5575 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/437 (2006.01); A61K 38/24 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 9/0034 (2013.01); A61K 9/0036 (2013.01); A61K 9/127 (2013.01); A61K 31/437 (2013.01); A61K 31/5575 (2013.01); A61K 38/24 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61K 47/42 (2013.01); A61K 47/44 (2013.01);
Abstract

An intravaginal device that provides biologically active circulating concentrations of an aromatase inhibitor for at least about of 4 days. Liposome-based and a wax-based formulations were used to assess letrozole diffusion through bovine vaginal mucosa in a diffusion chamber study. The wax-based vehicle was selected for further development of a letrozole intravaginal device based on its steady release rate. The addition of a letrozole-containing gel coating improved initial absorption and hastened the increase on plasma concentrations of the active ingredient, while the letrozole-containing wax-based vehicle maintained prolonged delivery from the intravaginal device.


Find Patent Forward Citations

Loading…